| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0021-9150(01)00458-0 |
| P698 | PubMed publication ID | 11583714 |
| P2093 | author name string | T Kobayashi | |
| H Matsuoka | |||
| Y Mori | |||
| S Nakano | |||
| N Kobayashi | |||
| H Shirataki | |||
| Y Tsubokou | |||
| P433 | issue | 2 | |
| P304 | page(s) | 359-368 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats | |
| P478 | volume | 158 |
| Q35115776 | Angiotensin II-induced hypertension blunts thick ascending limb NO production by reducing NO synthase 3 expression and enhancing threonine 495 phosphorylation |
| Q34973985 | Cardiac sequelae of hypertension |
| Q44237437 | Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats |
| Q57364644 | Chapter 11 Caveolin Proteins in Cardiopulmonary Disease and Lung Cancers |
| Q44459141 | Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function? |
| Q44776902 | Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism |
| Q46346105 | Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy? |
| Q34837722 | Physiological mechanisms regulating the expression of endothelial-type NO synthase. |
| Q34967386 | Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. |
| Q35090364 | The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases |
Search more.